CMS advises private equity firm Frontenac on acquisition of Newterra Group

Stuttgart – Frontenac Company (“Frontenac”) announced that it has acquired Newterra Group Ltd. (“Newterra” or the "Company"), a Global Modular Water Treatment Company, from its current shareholders including institutional investors XPV Water Partners and Angeleno Group, LLC. The financial terms of the transaction were not disclosed.

A CMS team led by Lead Partner Dr Tobias Grau provided comprehensive legal advice to Frontenac on the transaction in Germany.

Frontenac is a Chicago-based private equity firm. The firm focuses on investing in buyout transactions in the consumer, industrial, and services industries.

Newterra is a leader in designing, engineering, manufacturing, and servicing Modular Treatment Solutions for water, wastewater, and groundwater. Newterra's comprehensive portfolio of brands include Cochrane, TIGG, Aeration Industries, StormwateRx, Micro-Clear Membranes, EPRO and of course Newterra. The Company's customers include Private Developers, Industries, Institutions, Municipalities, EPC firms, Government entities, Food and Beverage companies, Remediation consultants and contractors and Aquaculture companies.

CMS Germany

Dr Tobias Grau, Lead Partner
Lena Stoll, Associate
Militsa Decheva Petrova, Associate, all Corporate/M&A
Dr Achim Lindemann, Partner
Dr Markus Meißner, Senior Associate, both Labor, Employment & Pensions 
Dr Stefan Voß, Partner
Lukas Potstada, Senior Associate, both Real Estate & Public
Dr Andreas Grunert, Counsel, Banking & Finance
Dr Martin Mohr, Counsel, Tax 
Birgit Wagner, Senior Legal Consultant
Anke Clippingdale, Legal Consultant
Steven Washington, Legal Consultant, all Smart Operations

Press Contact
presse@cms-hs.com